About the Authors
- Oscar M. Carrasco-Zevallos
-
* E-mail: omc3@duke.edu
Affiliation Department of Biomedical Engineering, Duke University, Durham, North Carolina, United States of America
- Derek Nankivil
-
Current address: Johnson & Johnson Vision Care Inc., Jacksonville, Florida, United States of America
Affiliation Department of Biomedical Engineering, Duke University, Durham, North Carolina, United States of America
- Christian Viehland
-
Affiliation Department of Biomedical Engineering, Duke University, Durham, North Carolina, United States of America
- Brenton Keller
-
Affiliation Department of Biomedical Engineering, Duke University, Durham, North Carolina, United States of America
- Joseph A. Izatt
-
Affiliations Department of Biomedical Engineering, Duke University, Durham, North Carolina, United States of America, Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina, United States of America
Competing Interests
At the time this study was conducted, Dr. Izatt was Chairman and Chief Scientific Advisor for Bioptigen, Inc. (since acquired by Leica Microsystems) and had corporate, equity, and intellectual property interests (including royalties) in this company. OMCZ, BK, CV, and JAI are inventors on pending patents pertaining to the technology described in this paper. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceptualization: OMCZ JAI. Data curation: OMCZ. Formal analysis: OMCZ DN JAI. Funding acquisition: JAI. Investigation: OMCZ DN CV BK JAI. Methodology: OMCZ DN CV BK JAI. Project administration: JAI. Resources: JAI. Software: OMCZ CV BK. Supervision: JAI. Validation: OMCZ DN. Visualization: OMCZ CV BK. Writing – original draft: OMCZ. Writing – review & editing: DN JAI.